专题：CNS Lymphoma Diagnosis and Treatment

This cluster of papers focuses on the diagnosis, treatment, and management of primary central nervous system lymphoma (PCNSL). It covers various aspects such as prognostic scoring systems, chemotherapy and radiotherapy regimens, use of methotrexate and rituximab therapy, genetic features, neurological masquerade syndromes, and cognitive functions in PCNSL patients.
最新文献
Nivolumab+AVD in Advanced-Stage Classic Hodgkin’s Lymphoma

article Full Text OpenAlex

Primary Bone Lymphoma of the Spine: A Case Report Highlighting Diagnostic Complexities and Treatment

article Full Text OpenAlex

The contemporary spectrum of radiotherapy for hematologic malignancies involving the central nervous system: From focal therapy to craniospinal

review Full Text OpenAlex

Role of Radiotherapy in the Management of Elderly Patients With Lymphoma

review Full Text OpenAlex

Teaching NeuroImage: Intracranial Cerebral Aneurysms Secondary to Epithelioid Hemangioendothelioma

article Full Text OpenAlex

The long‐term risk of immune‐related conditions in survivors of diffuse large B‐cell lymphoma: A Danish nationwide registry study

article Full Text OpenAlex

Coexistence of Diffuse Large B-Cell Lymphoma With Chronic Tubulointerstitial Nephritis: A Case Review and Pathophysiology

review Full Text OpenAlex

CLIPPERS With Supratentorial Brain and Cord Enhancement

article Full Text OpenAlex

Leptomeningeal Carcinomatosis From Primary Mucinous Carcinoma of the Ovary

article Full Text OpenAlex

Absence of enhancement in a lesion does not preclude primary central nervous system T-cell lymphoma: A case report

article Full Text OpenAlex

近5年高被引文献
Epidemiology of Non-Hodgkin’s Lymphoma

review Full Text OpenAlex 349 FWCI49.08547595

Pembrolizumab versus brentuximab vedotin in relapsed or refractory classical Hodgkin lymphoma (KEYNOTE-204): an interim analysis of a multicentre, randomised, open-label, phase 3 study

article Full Text OpenAlex 231 FWCI35.24558611

Brentuximab vedotin in combination with nivolumab in relapsed or refractory Hodgkin lymphoma: 3-year study results

article Full Text OpenAlex 191 FWCI29.34056645

Primary central nervous system lymphoma

review Full Text OpenAlex 183 FWCI56.52685973

Phase II Trial of Pembrolizumab Plus Gemcitabine, Vinorelbine, and Liposomal Doxorubicin as Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma

article Full Text OpenAlex 177 FWCI26.75712035

Primary central nervous system lymphoma

review Full Text OpenAlex 174 FWCI14.79062383

Immune checkpoint inhibitor-related hearing loss: a systematic review and analysis of individual patient data

review Full Text OpenAlex 145 FWCI48.91937291

T-Cell Lymphomas, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology

article Full Text OpenAlex 145 FWCI29.01835663

Consensus recommendations for MRI and PET imaging of primary central nervous system lymphoma: guideline statement from the International Primary CNS Lymphoma Collaborative Group (IPCG)

article Full Text OpenAlex 145 FWCI15.06201142

Primary vitreoretinal lymphoma: a diagnostic and management challenge

review Full Text OpenAlex 140 FWCI14.38354244